Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$685M |
| 2 |
BAS
Basis Energy Services, Inc.
BAS
|
+$459M |
| 3 |
WFT
Weatherford International plc
WFT
|
+$354M |
| 4 |
Air Products & Chemicals
APD
|
+$216M |
| 5 |
Mondelez International
MDLZ
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$3.97B |
| 2 |
Bank of America
BAC
|
+$1.16B |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$192M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$174M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.65% |
| 2 | Technology | 1.75% |
| 3 | Consumer Discretionary | 1.45% |
| 4 | Healthcare | 1.23% |
| 5 | Financials | 1.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Keurig Dr Pepper
KDP
$43.5B
| $4.29M | ﹤0.01% |
47,300
+37,900
| +403% | +$3.32M |
|
2652
GSK
GSK
$101B
| $4.29M | ﹤0.01% |
+89,073
| New | +$4.4M |
|
2653
CALL
Equity Lifestyle Properties
ELS
$12.5B
| $4.28M | ﹤0.01% |
118,600
+1,000
| +0.9% | +$35.7K |
|
2654
PUT
Lands' End
LE
$370M
| $4.28M | ﹤0.01% |
282,200
-25,100
| -8% | -$410K |
|
2655
CALL
McCormick & Company Non-Voting
MKC
$14.7B
| $4.28M | ﹤0.01% |
91,600
+25,400
| +38% | +$1.19M |
|
|
FMI
2656
PUT
DELISTED
Foundation Medicine, Inc.
FMI
| $4.27M | ﹤0.01% |
241,400
-40,700
| -14% | -$877K |
|
2657
ProShares Ultra Russell2000
UWM
$255M
| $4.26M | ﹤0.01% |
153,088
+141,748
| +1,250% | +$3.55M |
|
2658
Everest Group
EG
$14.4B
| $4.26M | ﹤0.01% |
19,700
+3,900
| +25% | +$804K |
|
2659
Tenet Healthcare
THC
$21.7B
| $4.26M | ﹤0.01% |
287,073
+34,479
| +14% | +$619K |
|
2660
CALL
Trex
TREX
$4.71B
| $4.26M | ﹤0.01% |
264,400
+128,000
| +94% | +$2M |
|
2661
PUT
Open Text
OTEX
$6.1B
| $4.25M | ﹤0.01% |
137,600
+49,600
| +56% | +$1.55M |
|
|
PTLA
2662
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.25M | ﹤0.01% |
189,500
+12,200
| +7% | +$238K |
|
2663
PUT
Exelixis
EXEL
$13.7B
| $4.25M | ﹤0.01% |
284,900
-420,500
| -60% | -$6.07M |
|
|
DBD
2664
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
| $4.25M | ﹤0.01% |
168,900
+124,400
| +280% | +$2.93M |
|
2665
CALL
BioCryst Pharmaceuticals
BCRX
$2.5B
| $4.25M | ﹤0.01% |
670,800
+499,800
| +292% | +$2.6M |
|
2666
Deckers Outdoor
DECK
$11.9B
| $4.24M | ﹤0.01% |
+459,330
| New | +$4.42M |
|
2667
CALL
Ultragenyx Pharmaceutical
RARE
$2.58B
| $4.24M | ﹤0.01% |
60,300
-14,900
| -20% | -$1.06M |
|
2668
Brown-Forman Class B
BF.B
$12.7B
| $4.24M | ﹤0.01% |
147,406
+40,453
| +38% | +$1.18M |
|
2669
New Oriental
EDU
$9.15B
| $4.24M | ﹤0.01% |
100,664
+774
| +0.8% | +$36.5K |
|
|
CDK
2670
PUT
DELISTED
CDK Global, Inc.
CDK
| $4.24M | ﹤0.01% |
71,000
-13,300
| -16% | -$761K |
|
|
EXPR
2671
DELISTED
Express, Inc.
EXPR
| $4.24M | ﹤0.01% |
19,689
+3,376
| +21% | +$829K |
|
|
ENLC
2672
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $4.24M | ﹤0.01% |
222,339
-12,844
| -5% | -$220K |
|
2673
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$296M
| $4.23M | ﹤0.01% |
+103,666
| New | +$3.91M |
|
|
FMI
2674
DELISTED
Foundation Medicine, Inc.
FMI
| $4.23M | ﹤0.01% |
239,057
+114,425
| +92% | +$2.47M |
|
2675
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.9B
| $4.23M | ﹤0.01% |
49,341
-5,326
| -10% | -$463K |
|
Similar funds
Jeff Yass's Q4 2016 Portfolio in Review
As of Q4 2016, Jeff Yass held 10,783 positions worth $197B, down 4.9% from $207B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jeff Yass's Q4 2016 filing shows 2,442 new, 3,513 increased, 3,383 reduced and 1,274 closed positions. Its largest new stake was Basis Energy Services, Inc.: 1,689,160 shares worth $59.7M. The largest sale was Procter & Gamble, an estimated $3.97B.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2016 buy was Basis Energy Services, Inc.: 1,689,160 shares worth $59.7M.
- Jeff Yass added most to Amazon in Q4 2016, an estimated $685M increase.
- Jeff Yass's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $3.97B.
- Jeff Yass fully exited Synchrony in Q4 2016, selling an estimated $104M.
- Jeff Yass's ten largest holdings make up 21% of its $197B portfolio in Q4 2016.
- Jeff Yass opened 2,442 new positions and closed 1,274 in Q4 2016.
- Jeff Yass's portfolio value fell 4.9% quarter-over-quarter to $197B.
Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.